11 Jan 2019 Governance
Leukaemia UK and Leuka have merged
We are delighted to announce that on 1 November Leuka and Leukaemia UK merged, bringing together two of the UK’s leading leukaemia and blood cancer charities to create one charity dedicated to innovative research and care for people affected by blood cancers. The two charities have joined forces under the name Leukaemia UK, uniting Leuka’s 37 years’ experience in ground-breaking medical research with Leukaemia UK’s four decades of pioneering care.
From research to care, the new charity will continue to put people affected by blood cancers at its heart. Together, Leukaemia UK aims to carry out even more world-class research and advances in care.
Leukaemia UK will be led jointly by Leuka’s CEO Olive Boles and Leukaemia UK’s CEO Angela Smith-Morgan. The charity’s new Chair of Trustees is Chris Corbin, current Chair of Leuka, who is supported by a Board including both Leuka and Leukaemia UK Trustees.
Related posts
31 October 2023
Chris Dew joins Leukaemia UK as Director of Finances & Resources
Leukaemia UK is delighted to announce the appointment of Chris Dew as Director of Finance & Resources, following ten years as Chief Financial Officer at musical therapy charity Nordoff-Robbins. The…
4 April 2022
Leukaemia UK launches search for five new talented Trustees
We are looking for a talented and diverse set of Trustees to join our Board, and help guide the charity as we embark on an ambitious new strategy to accelerate progress in leukaemia research to stop leukaemia devastating lives.
20 October 2023
Emerging leaders accolade for former Leukaemia UK John Goldman Fellows
Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…
24 September 2021
Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients
Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).